The purposes of this study were (a) to describe the clinical and biochemical manifestations associated with spontaneous reactivation of hepatitis B virus as defined by the reappearance of hepatitis B virus DNA in serum using dot-blot hybridization and (b) to determine whether the clinical and bioche
Spontaneous reactivation of hepatitis B in Chinese patients with Hbsag-positive chronic active hepatitis
β Scribed by Myron J. Tong; Richard E. Sampliner; Sugantha Govindarajan; Ruth L. Co
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 808 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Eleven patients of Chinese origin experienced spontaneous reactivation of chronic active hepatitis B. Eight
HBsAg-positive patients were followed for an average of 15 months prior to, while three others presented during reactivation. Fatigue, hepatomegaly and jaundice were frequent findings. Elevation of both serum ALT (average = 1,212 units per liter) and hepatitis B virus DNA levels were noted in all patients, and reactivation lasted an average of 4.4 months. During resolution, clinical symptoms abated, serum ALT levels reverted toward normal, and in nine patients, the hepatitis B virus DNA values became undetectable. All patients lacked evidence for acute hepatitis A, Epstein-Barr Virus, cytomegalovirus or hepatitis delta virus infection.
Histologic findings of liver tissue from eight patients showed piecemeal necrosis and fibrosis. Within the parenchyma, varying degrees of hepatocytolysis with cuffing, perivenular necrosis and acidophilic bodies were noted. Ground-glass cells and regenerative changes also were observed. Cirrhosis was not present in any of the liver biopsies.
These findings suggest that spontaneous reactivation of hepatitis B occurs in heterosexual patients with chronic active hepatitis B and contributes to chronic inflammation and to the progression of their liver disease.
Chronic active hepatitis B (CAH-B) is a progressive disease which ultimately leads to cirrhosis and possible development of primary hepatocellular carcinoma (PHC). Approximately 3% of adult patients who contract acute icteric hepatitis go on to CAH-B (1). However, the majority of CAH-B patients who present to the physician have no previous history of jaundice or hepatitis, and presumably acquire their disease via a subclinical infection. In Asian countries, this may occur by neonatal transmission from an asymptomatic HBsAg-positive mother to her infant or exposure to hepatitis B during early childhood.
Four long-term follow-up studes of adult patients with CAH-B have shown that, during a mean follow-up of 49 months, 42% of 136 patients had clinical and biochemical
π SIMILAR VOLUMES
CAH based on established criteria (7) and evidence of liver disease for greater than 6 months, were included in this study. Age, sex, drug history, alcohol intake and predisposing factors to HBV infection were recorded.
The natural history of chronic hepatitis B patients who spontaneously cleared serum HBsAg was investigated. A total of 351 patients with chronic hepatitis B were observed in our hospital for at least 3 yr. Seven of these patients became HBsAg negative during the follow-up period. HBsAg disappeared w
Spontaneous loss of HBsAg is infrequent in adult HBV carriers. Little is known about this serological change in children. In a prospective study of 420 hepatitis B virus-carrier children who were observed for 1 to 12 yr (mean = 4.3 yr), spontaneous loss of HBsAg occurred in 10 patients, with an aver
The objective of this study was to evaluate the role of hepatitis B virus (HBV) precore mutations in patients with anti-me-positive chronic hepatitis B with or without previous known HBe antigen (HBeAg) viremic phase, and to assess the potential implication of precore mutants in HBeAg-negative react
## Abstract A study was conducted during a 1 year followβup to characterize the viral kinetics in hepatitis B e antigen (HBeAg)βpositive chronic hepatitis B and to develop a model of predicting the probability of spontaneous HBeAg seroconversion. Fiftyβseven patients with HBeAgβpositive chronic hep